At a glance
ClinicalIndex Comparison RecordN/ACompleted· 93 enrolled
Drug / intervention
PillCam ESO Capsule Endoscopeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CEPELA I Trial: Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
In Brief
A clinical study evaluating PillCam ESO Capsule Endoscope for Esophageal Lesion. Completed, enrolled 93 participants across 1 site.
Detailed Summary
This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient's esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Lesion
CountriesUnited States
CollaboratorsMedtronic - MITG
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedOct 2009
Primary CompletionJun 2010
Study CompletionSep 2010
TodayJul 2026
First PostedOct 7, 2009
Enrollment StartSep 1, 2009
Primary CompletionJun 1, 2010
Study CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.7 years ago
Interventions
PillCam ESO Capsule Endoscopeother
Utilization of the PillCam ESO capsule endoscope to evaluate the condition of a patient's esophagus before and after RFA therapy to treat atrial fibrillation.